Published in Hepatology on May 01, 2000
Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol (2008) 1.60
Hepatitis C virus infection and apoptosis. World J Gastroenterol (2007) 1.36
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer (2004) 1.14
Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res (2005) 1.13
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol (2002) 1.05
Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg (2002) 1.04
Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells. World J Gastroenterol (2004) 0.87
Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection. BMC Microbiol (2008) 0.86
Hepatitis C virus-induced mitochondrial dysfunctions. Viruses (2013) 0.84
Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology (2011) 0.83
Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy. World J Gastroenterol (2005) 0.83
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients. PLoS One (2013) 0.82
Caspase inhibitors for the treatment of hepatitis C. Clin Liver Dis (2009) 0.82
Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells. Apoptosis (2011) 0.81
Characterization of chronic HCV infection-induced apoptosis. Comp Hepatol (2011) 0.81
Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice. J Virol Methods (2007) 0.80
Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10, and GM-CSF. Indian J Hematol Blood Transfus (2011) 0.79
Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector. Virol J (2008) 0.79
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med (2012) 0.78
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol (2016) 0.77
Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection. PLoS One (2016) 0.77
Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line. Virol J (2011) 0.77
Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cells. Virol J (2012) 0.77
TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications. PLoS One (2014) 0.76
Hepatitis C Virus Infection of Cultured Human Hepatoma Cells Causes Apoptosis and Pyroptosis in Both Infected and Bystander Cells. Sci Rep (2016) 0.75
Deficiency of iPLA₂β Primes Immune Cells for Proinflammation: Potential Involvement in Age-Related Mesenteric Lymph Node Lymphoma. Cancers (Basel) (2015) 0.75
Mechanism of Hepatocyte Apoptosis. J Cell Death (2016) 0.75
Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis. Med Sci Monit (2017) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation (1996) 3.82
HCV-associated liver cancer without cirrhosis. Lancet (1995) 3.23
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet (1992) 2.44
Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg (1997) 2.43
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Natural history of hepatitis C. J Hepatol (1999) 2.31
Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology (1993) 2.29
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut (2004) 2.22
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04
Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A (1984) 2.00
Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol (1989) 2.00
Screening of thalassaemia carriers in intermediate school of Latium: results of four years' work. J Med Genet (1980) 1.94
Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol (1993) 1.84
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer (1994) 1.81
Intersubject variability of real-ear sound pressure level: conventional and insert earphones. J Am Acad Audiol (1994) 1.76
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature (1990) 1.74
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther (2011) 1.73
Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis (1991) 1.69
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Pulmonary inflammatory myofibroblastic tumour with unusual octreoscan uptake: two reports. Eur Respir J (2010) 1.68
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63
Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut (1982) 1.60
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology (1989) 1.59
Incorrect echocardiographic diagnosis in patients with mechanical prosthetic valve dysfunction: correlation with surgical findings. Am J Med (2000) 1.55
Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat (2007) 1.54
A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology (1992) 1.52
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther (2011) 1.51
Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol (1992) 1.50
Mediterranean Adequacy Index: correlation with 25-year mortality from coronary heart disease in the Seven Countries Study. Nutr Metab Cardiovasc Dis (2004) 1.49
Dynamic in vitro calcification of bioprosthetic porcine valves: evidence of apatite crystallization. J Thorac Cardiovasc Surg (2001) 1.49
Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J (Clin Res Ed) (1984) 1.49
Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta (1982) 1.48
Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia (1999) 1.48
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha. J Hepatol (1994) 1.43
Dispersal flight by Triatoma infestans in an arid area of Argentina. Med Vet Entomol (1988) 1.43
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. Neurology (2006) 1.42
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Gut (1977) 1.42
Food habits in a southern Italian town (Nicotera) in 1960 and 1996: still a reference Italian Mediterranean diet? Diabetes Nutr Metab (2001) 1.41
ICHD 2nd Edition: Some considerations on the application of criteria for primary headache. Cephalalgia (2005) 1.41
Primary right atrial fibrosarcoma diagnosed by endocardial biopsy. Am Heart J (1996) 1.39
Mees' lines due to cyclosporin. Br J Dermatol (1999) 1.39
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology (1986) 1.38
[Coronary angioplasty in an Italian hospital without on-site cardiac surgery: the results and outlook]. G Ital Cardiol (1994) 1.38
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology (1994) 1.37
Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia (1999) 1.37
Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol (1976) 1.35
Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia (2000) 1.32
Tracheal diverticulum: a rare cause and consequence of chronic cough. Eur J Surg (1994) 1.32
Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J (1978) 1.31
Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat (2006) 1.26
Hyperargininemia. J Pediatr (1977) 1.26
Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology (1986) 1.26
Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev (2009) 1.25
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology (1997) 1.24
Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology (1982) 1.24
Comparison of established and emerging biodosimetry assays. Radiat Res (2013) 1.23
Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis (1987) 1.23
Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials (2000) 1.23
Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology (1988) 1.23
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Endomyocardial biopsy in right ventricular cardiomyopathy. Int J Cardiol (1993) 1.21
T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology (1985) 1.20
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. Gut (1998) 1.20
The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol (1995) 1.19
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut (2003) 1.17
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem (2001) 1.17
Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr (2001) 1.17
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Clin Exp Immunol (1987) 1.16
Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity. Pharmacol Res Commun (1985) 1.16
Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. Eur J Gastroenterol Hepatol (2000) 1.16
Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study. Sleep Med (2010) 1.15
The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol (1995) 1.14